ASPI Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q3

FY2025Q4

FY2026Q1

2.03M

+70.09%

-0.100

-16.67%

5.06M

+359.33%

-0.140

+7.69%

8.63M

+620.02%

-0.137

+13.89%

Estimates Revision

The market is revising Downward the revenue expectations for ASP Isotopes Inc. (ASPI) for FY2025, with the revenue forecasts being adjusted by -13.63% over the past three months. During the same period, the stock price has changed by -25.86%.

Revenue Estimates for FY2025

Revise Downward

-13.63%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+2.04%

In Past 3 Month

Stock Price

Go Down

-25.86%

In Past 3 Month

2 Analyst Rating

Wall Street analysts forecast ASPI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASPI is 13.00 USD with a low forecast of 11.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

11.00

Averages

13.00

High

15.00

Current: 0.000

Low

11.00

Averages

13.00

High

15.00

Cantor Fitzgerald

Derek Soderberg

Overweight

initiated

$13

2025-12-04

Reason

Cantor Fitzgerald

Derek Soderberg

Price Target

$13

2025-12-04

initiated

Overweight

Reason

Cantor Fitzgerald analyst Derek Soderberg initiated coverage of ASP Isotopes (ASPI) with an Overweight rating and $13 price target. ASP Isotopes has developed advanced isotope-enrichment technology that produces high-value nuclear fuel, medical isotopes, and silicon-28, and currently stands as the sole commercial-scale provider of certain isotopes, the analyst tells investors in a research note. The pending acquisition of Renergen (RGNNF) could give ASPI control of the world's largest high-concentration helium deposit, while the planned spinout of its quantum laser enrichment technology represents a near-term value-creation opportunity, Cantor says.

Cantor Fitzgerald

Derek Soderberg

initiated

$13

2025-12-04

Reason

Cantor Fitzgerald

Derek Soderberg

Price Target

$13

2025-12-04

initiated

Reason

Cantor Fitzgerald analyst Derek Soderberg initiated coverage of ASP Isotopes with an Overweight rating and $13 price target.

Lucid Capital

Alex Fuhrman

Buy

initiated

$15

2025-10-27

Reason

Lucid Capital

Alex Fuhrman

Price Target

$15

2025-10-27

initiated

Buy

Reason

Lucid Capital analyst Alex Fuhrman initiated coverage of ASP Isotopes with a Buy rating and $15 price target. The company is "entering a phase of rapid growth" as it transitions to commercial production of isotopes with the potential to transform a wide range of high-tech industries, the analyst tells investors in a research note. The firm sees ASP as well positioned to help reduce the West's dependence on Russian isotope supplies critical to medicine and nuclear power.

Canaccord

Buy

upgrade

$11

2025-05-21

Reason

Canaccord

Price Target

$11

2025-05-21

upgrade

Buy

Reason

Canaccord raised the firm's price target on ASP Isotopes to $11 from $8.50 and keeps a Buy rating on the shares. The firm said they are positive on the multiple definitive agreements with TerraPower, "related to financing support for the construction of a new uranium enrichment facility capable of producing High Assay Low-Enriched Uranium (HALEU), and the future supply of HALEU to TerraPower, as a customer." Canaccord raised its estimates and they see room for further upside with the announced transaction and management's ability to execute.

Valuation Metrics

The current forward P/E ratio for ASP Isotopes Inc (ASPI.O) is -10.97, compared to its 5-year average forward P/E of -17.82. For a more detailed relative valuation and DCF analysis to assess ASP Isotopes Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-17.82

Current PE

-10.97

Overvalued PE

-0.85

Undervalued PE

-34.80

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-2.81

Current EV/EBITDA

-64.47

Overvalued EV/EBITDA

34.80

Undervalued EV/EBITDA

-40.43

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

14.68

Current PS

23.47

Overvalued PS

25.81

Undervalued PS

3.55

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

ASPI News & Events

Events Timeline

No data

News

8.0

01-09NASDAQ.COM

Darling Ingredients (DAR) Sees 11,987 Options Contracts Traded, 60.6% of Average Volume

2.0

01-09Benzinga

CG Oncology Accelerates Phase 3 Data Readout to First Half of 2026

7.0

01-02PRnewswire

ASP Isotopes Under Investigation Amid Securities Class Action Lawsuit

People Also Watch

Frequently Asked Questions

What is ASP Isotopes Inc (ASPI) stock price today?

The current price of ASPI is 7.51 USD — it has increased 16.61 % in the last trading day.

What is ASP Isotopes Inc (ASPI)'s business?

ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. Its proprietary technologies, the Aerodynamic Separation Process and Quantum Enrichment technology, are designed to enable the production of isotopes used in several industries. Its initial focus is on the production and commercialization of enriched Carbon-14 (C-14), Silicon-28 (Si-28) and Ytterbium-176 (Yb-176). It is also a provider of liquid helium with operations at the Virginia Gas Project in South Africa. Its nuclear fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its specialist isotopes and related services segment is focused on research and development of technologies and methods used to separate isotopes for highly specialized target end markets.

What is the price predicton of ASPI Stock?

What is ASP Isotopes Inc (ASPI)'s revenue for the last quarter?

ASP Isotopes Inc revenue for the last quarter amounts to 4.89M USD, increased 349.53 % YoY.

What is ASP Isotopes Inc (ASPI)'s earnings per share (EPS) for the last quarter?

ASP Isotopes Inc. EPS for the last quarter amounts to -0.15 USD, increased 25.00 % YoY.

What changes have occurred in the market's expectations for ASP Isotopes Inc (ASPI)'s fundamentals?

How many employees does ASP Isotopes Inc (ASPI). have?

ASP Isotopes Inc (ASPI) has 136 emplpoyees as of January 10 2026.

What is ASP Isotopes Inc (ASPI) market cap?

Today ASPI has the market capitalization of 939.58M USD.